Skip to main content
. 2022 Mar 29;24:78. doi: 10.1186/s13075-022-02759-0

Fig. 4.

Fig. 4

WOMAC Physical Function responders. The proportion of patients achieving ≥30% (A), ≥50% (B), ≥70% (C), or ≥90% (D) reductions from baseline in WOMAC Physical Function at weeks 2, 4, 8, 16, and 56 is shown. Proportions shown above each bar are rounded to the nearest percent. *Unadjusted p ≤ 0.05 versus NSAID. NSAID, nonsteroidal anti-inflammatory drug; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index